Clinical TrialsPaid Clinical Trials in North Carolina
Reviewed by Michael Gill, B. Sc.
Image of ForCare Clinical Research in Tampa, United States.
Phase-Based Progress Estimates
2
Effectiveness
3
Safety

Abrocitinib 100 Mgfor Eczema, Infantile

Any Age
All Sexes
This trial is studying whether a new drug, abrocitinib, is effective and safe for treating atopic dermatitis in patients aged 12 years and older. The trial consists of an initial treatment period of 92 weeks, followed by a secondary treatment period of variable length during which subjects will receive treatment with open-label abrocitinib until availability of commercial product in their country, or until the sponsor terminates the study in that country. There is also a sub-study evaluating whether abrocitinib has any potential effects on adolescent bone with regard to abnormal bone findings in knee MRI.
Phase 3
Waitlist Available
ForCare Clinical Research (+8 Sites)Pfizer CT.gov Call CenterPfizer
25 Paid Studies North Carolina Near Me
Top Cities for Paid Studies North Carolina
Image of Anchorage in Alaska.
Anchorage
206Active Trials
Providence Alaska Medical CenterTop Active Site
Image of Los Angeles in California.
Los Angeles
194Active Trials
Kaiser Permanente Los Angeles Medical CenterTop Active Site